ð¡ã³ããåŸéºçæ£è ãžã®éå£å¿ççæ³ã®åœ±é¿ã調ã¹ãç ç©¶ïŒãã®å¹æãšä»åŸã®å±æ
æ°åã³ãããŠã€ã«ã¹ææçïŒSARS-CoV-2ïŒã«çœ¹æ£ããåŸãå€ãã®äººãé·æéã«ããã£ãŠæ§ã ãªçç¶ã«æ©ãŸãããŠããŸãããããã¯ãã³ããåŸéºçïŒPost-COVID-19 condition, PCSïŒããšåŒã°ããç²åŽæãæ¯åããé çãéäžåã®äœäžãèšæ¶é害ãªã©ãå€å²ã«ããã身äœçã»ç²Ÿç¥çãªçç¶ãå«ãŸããŸãããããã®çç¶ã¯ãæ¥åžžç掻ã瀟äŒç掻ã«å€§ããªåœ±é¿ãäžããããšãå°ãªããããŸãããçç©åŠçãªèŠå ã ãã§ãªããå¿ç瀟äŒçèŠå ãçç¶ã®æç¶ã«é¢äžããŠãããšèããããŠãããå¿ççæ³ãçç¶è»œæžã«åœ¹ç«ã€å¯èœæ§ã泚ç®ãããŠããŸããããããã³ããåŸéºçã«ç¹åããéå£å¿ççæ³ã®å¹æã«ã€ããŠã¯ããŸã ååãªç ç©¶ããããŸããã§ãããä»åã玹ä»ããç ç©¶ã¯ããã®èª²é¡ã«åãçµãã ãã®ã§ãã
ðç ç©¶æŠèŠ
ãã®ç ç©¶ã¯ãã³ããåŸéºçã«æ©ãæ£è ããã«å¯Ÿããéå£å¿ççæ³ã®å¹æãæ€èšŒããããšãç®çãšããŠããŸããç¹ã«ãç²åŽæãèªç¥æ©èœã®èšŽããšãã£ãæç¶çãªèº«äœçç¶ã«çŠç¹ãåœãŠãå¿ççæ³ããããã®çç¶ãæãã€ãäžå®ãšãã£ã粟ç¥çç¶ã«ã©ã®ãããªåœ±é¿ãäžãããã調ã¹ãŠããŸãããããŸã§ã®ç ç©¶ã§ã¯ãã³ããåŸéºçã«å¯Ÿããéå£å¿ççæ³ã®æå¹æ§ã瀺ããšããã³ã¹ïŒç§åŠçæ ¹æ ïŒãéãããŠããããããã®ç ç©¶ã¯è²Žéãªäžæ©ãšãªããŸãã
ð¬ç ç©¶æ¹æ³
ãã®ç ç©¶ã¯ãç¡äœçºååŸ æ©ãªã¹ãå¯Ÿç §ã¯ãã¹ãªãŒããŒç ç©¶ãšããæ¹æ³ã§è¡ãããŸãããããã¯ãåå è ãã©ã³ãã ã«2ã€ã®ã°ã«ãŒãã«åããäžæ¹ã¯ããã«æ²»çãåããããäžæ¹ã¯åŸ æ©æéåŸã«æ²»çãåããç ç©¶ãã¶ã€ã³ã§ããåŸ æ©æéåŸã«ã¯ãåŸ æ©çŸ€ãæ²»çãåããããšãã§ããŸãã
åå è
éå»ã«SARS-CoV-2æææŽããããæ©èœé害ã䌎ãæç¶çãªçç¶ãæã€æäºº48åãåå ããŸããã
å¹³å幎霢ã¯53.3æ³ã§ãçŽ68.8%ã女æ§ã§ããã
ã°ã«ãŒãåã
ä»å
¥çŸ€ (IG)ïŒããã«éå£å¿ççæ³ãéå§ããã°ã«ãŒãïŒ21åïŒã
察ç
§/åŸ
æ©çŸ€ (CG)ïŒéåžžæ²»çãåããªãããéå£å¿ççæ³ãé
ããŠéå§ããã°ã«ãŒãïŒ27åïŒã
ä»å ¥å 容
ä»å
¥çŸ€ã«æäŸãããéå£å¿ççæ³ã¯ã10åã®éé±ã»ãã·ã§ã³ïŒ1å50åïŒã§æ§æãããŠããŸããã
ãã®ã»ãã·ã§ã³ã¯ããã¥ã¢ã«ã«æ²¿ã£ãŠè¡ããã以äžã®å
容ãå«ãŸããŠããŸããã
å¿çæè²ïŒç
æ°ãæ²»çã«ã€ããŠæ£ããç¥èãæäŸããæ£è
ããèªèº«ãç
æ°ãšåãåãåãé«ããæè²ã§ããã³ããåŸéºçã®çç¶ãã¡ã«ããºã ã«ã€ããŠåŠã³ãçè§£ãæ·±ããŸãã
身äœçç¶ã®åŠçïŒæç¶ãã身äœçç¶ïŒç²åŽãçã¿ãªã©ïŒãšã®åãåãæ¹ãå¯ŸåŠæ³ãåŠã³ãŸãã
ææ
調æŽïŒçç¶ã«äŒŽãäžå®ãæãã€ãšãã£ãææ
ãèªèããé©åã«ç®¡çããæ¹æ³ãåŠã³ãŸãã
瀟äŒåŸ©åž°ïŒæ¥åžžç掻ãç€ŸäŒæŽ»åãžã®åŸ©åž°ãæ¯æŽããããã®æŠç¥ãåŠã³ãŸãã
è©äŸ¡é ç®
äž»èŠè©äŸ¡é
ç®ïŒ
身äœçç¶ã®è² æ
床 (SSS-8)ïŒèº«äœçç¶ã®éçåºŠãæž¬ã尺床ã§ãã
坿¬¡è©äŸ¡é
ç®ïŒ
æãã€çç¶ (PHQ-9)ïŒæãã€çç¶ã®éçåºŠãæž¬ã尺床ã§ãã
äžå®çç¶ (GAD-7)ïŒäžå®çç¶ã®éçåºŠãæž¬ã尺床ã§ãã
ã¢ãã¬ãŒã¿ãŒïŒ
å°å
æã®èåŸ
(CTS)ïŒå°å
æã®èåŸ
çµéšãä»å
¥å¹æã«åœ±é¿ãäžãããã©ããã調ã¹ãŸããã
ããŒã¿è§£æ
ããŒã¹ã©ã€ã³ïŒç ç©¶éå§æïŒã®çç¶ã®éç床ã調æŽããå
±åæ£åæïŒANCOVAïŒãšããçµ±èšææ³ãçšããŠãä»å
¥çŸ€ãšå¯Ÿç
§çŸ€ã®çµæãæ¯èŒããŸãããANCOVAã¯ãä»ã®èŠå ã®åœ±é¿ã調æŽããªãããã°ã«ãŒãéã®å¹³åå€ã®éããæ¯èŒããçµ±èšææ³ã§ãã
3ã¶æåŸã®è¿œè·¡èª¿æ»ãè¡ãããŸããããããã¯èšè¿°çã»æ¢çŽ¢çã«åæãããŸããã
ðäž»ãªç ç©¶çµæ
ç ç©¶éå§æïŒããŒã¹ã©ã€ã³ïŒã®åå è ã®ç¶æ³ã¯ã身äœçç¶ã®è² æ 床ãé«ããèšåºçã«é¢é£ããæãã€çç¶ãšäžçšåºŠã®äžå®ãèŠãããŸãããç¹ã«ãç²åŽé¢é£ã®èº«äœçæ¶èãšèªç¥æ©èœã®èšŽããæãé¡èãªçç¶ã§ããã
ããããéå£å¿ççæ³ä»å ¥ã®å¹æãæ€èšŒããçµæã以äžã®ç¹ãæããã«ãªããŸããã
| è©äŸ¡é ç® | ä»å ¥çŸ€ãšå¯Ÿç §çŸ€ã®æ¯èŒ | çµ±èšçæææ§ (på€) | çµæã®è§£é |
|---|---|---|---|
| 身äœçç¶ã®è² æ 床 (SSS-8) | ææãªå·®ãªã (β = -2.20) | p = 0.091 | ä»å ¥çŸ€ã§ããããªæ¹ååŸåã¯èŠããããã®ã®ãçµ±èšçã«ã广ããã£ãããšã¯èšããªãçµæã§ããã |
| æãã€çç¶ (PHQ-9) | ææãªå·®ãªã (β = -1.77) | p = 0.251 | ä»å ¥çŸ€ãšå¯Ÿç §çŸ€ã®éã§ãæãã€çç¶ã«çµ±èšçã«ææãªå·®ã¯èŠãããŸããã§ããã |
| äžå®çç¶ (GAD-7) | ææãªå·®ãªã (β = -0.81) | p = 0.588 | ä»å ¥çŸ€ãšå¯Ÿç §çŸ€ã®éã§ãäžå®çç¶ã«çµ±èšçã«ææãªå·®ã¯èŠãããŸããã§ããã |
ããŒã¹ã©ã€ã³ã®çç¶ã®éç床ïŒç ç©¶éå§æã®çç¶ã®éç床ãããã®åŸã®çµæã匷ãäºæž¬ããããšã瀺ãããŸããïŒp < 0.001ïŒãããã¯ãããšããšçç¶ãéã人ã»ã©ããã®åŸã®çç¶ãéãåŸåãããããšãæå³ããŸãã
å°å
æã®èåŸ
(CTS)ïŒå°å
æã®èåŸ
çµéšã¯ãä»åã®éå£å¿ççæ³ã®å¹æã匷ããã匱ãããããèŠå ïŒã¢ãã¬ãŒã¿ãŒïŒã§ã¯ãããŸããã§ããã
ð€ç ç©¶ããã®èå¯
ãã®æ¢çŽ¢çãªç¡äœçºåæ¯èŒè©Šéšã§ã¯ãã³ããåŸéºçæ£è ããã«å¯Ÿããéå£å¿ççæ³ã¯ãå¯Ÿç §çŸ€ãšæ¯èŒããŠçµ±èšçã«ææãªåªäœæ§ã瀺ãã«ã¯è³ããŸããã§ããã
ãã®çµæã«ã€ããŠãç ç©¶è ãã¡ã¯ããã€ãã®éèŠãªèå¯ãè¿°ã¹ãŠããŸãã
1. çµ±èšçæ€åºåã®éçïŒä»åã®ç ç©¶ã¯åå è
æ°ãéãããŠãããããçµ±èšçæ€åºåïŒçµ±èšçãªæ€å®ã«ãããŠãå®éã«å¹æãããå Žåã«ãããæ£ããæ€åºã§ãã確çïŒãååã§ã¯ãªãã£ãå¯èœæ§ããããŸããå®éã«ã¯å¹æããã£ããšããŠããåå è
æ°ãå°ãªãããã«ã广ãªãããšçµè«ä»ããŠããŸã£ãå¯èœæ§ãåŠå®ã§ããŸããã
2. è©äŸ¡é
ç®ã®èª²é¡ïŒä»åŸã®ã³ããåŸéºçæ£è
ããã«å¯Ÿããéå£å¿ççæ³ã§ã¯ãæç¶çãªèº«äœçç¶ã®éç床ãšãã£ãäžè¬çãªçç¶ã¹ã³ã¢ã ãã§ãªãããã倿§ãªè©äŸ¡é
ç®ãæ€èšããå¿
èŠããããããããŸãããäŸãã°ãç¹å®ã®çç¶ïŒç²åŽã®è³ªãèªç¥æ©èœã®å
·äœçãªåŽé¢ãªã©ïŒããçæŽ»ã®è³ªã瀟äŒåå ã®åºŠåããšãã£ããæ£è
ããã®å®ç掻ã«å³ããã¢ãŠãã«ã ïŒçµæïŒãè©äŸ¡ããããšãéèŠã§ãã
3. åå¥åã®éèŠæ§ïŒéå£ããŒã¹ã®å¿ççæ³ã§ãã£ãŠããåã
ã®æ£è
ããã®ããŒãºã«åãããŠæè»ã«é©å¿ã§ãããããªã¢ãããŒããããã广çã§ããå¯èœæ§ããããŸããã³ããåŸéºçã®çç¶ã¯æ£è
ããã«ãã£ãŠå€§ããç°ãªããããäžåŸã®ããã°ã©ã ã§ã¯å¯Ÿå¿ããããªãéšåããããããããŸããã
4. å±€å¥åã®å¯èœæ§ïŒç ç©¶éå§æã®çç¶ã®éç床ããç²åŽã®éç床ããã©ãŠãæŽãšãã£ãäž»èŠãªçç¶ãããã¡ã€ã«ã«ãã£ãŠæ£è
ãããå±€å¥åïŒã°ã«ãŒãåãïŒããããšã§ãèšåºçã«æå³ã®ããå€åãæããæåºŠãé«ããããšãã§ãããããããŸãããäŸãã°ãé床ã®ç²åŽã蚎ããæ£è
ããã«ã¯ããã®ç²åŽã«ç¹åããä»å
¥ããã广çã§ããå¯èœæ§ããããŸãã
ð¡å®ç掻ãžã®ã¢ããã€ã¹
ä»åã®ç ç©¶çµæã¯ãéå£å¿ççæ³ãã³ããåŸéºçã«ãäžèœè¬ãã§ã¯ãªãããšã瀺åããŠããŸãããã ãããšãã£ãŠå¿ççæ³ãç¡æå³ãšããããã§ã¯ãããŸãããã³ããåŸéºçã«æ©ãæ¹ãå®ç掻ã§çç¶ãšåãåãããã®ãã³ããããã€ãã玹ä»ããŸãã
çç¶ã¯äžäººã²ãšãç°ãªãããšãçè§£ããïŒã³ããåŸéºçã®çç¶ã¯éåžžã«å€æ§ã§ãããèªèº«ã®çç¶ãã©ã®ãããªãã®ããäœãæãã€ããã®ããæç¢ºã«ããããšããé©åãªãµããŒããèŠã€ããç¬¬äžæ©ã§ãã
å°éå®¶ãžã®çžè«ããããããªãïŒç²åŽãèªç¥æ©èœã®äœäžãæãã€ãäžå®ãªã©ãçç¶ãé·åŒãå Žåã¯ãå°éå»ïŒå
ç§ã粟ç¥ç§ãå¿çå
ç§ãªã©ïŒãã«ãŠã³ã»ã©ãŒã«çžè«ããŸããããäžäººã§æ±ã蟌ãŸããå°éå®¶ã®å©ããåããããšã倧åã§ãã
èªå·±ç®¡çã®éèŠæ§ïŒååãªäŒæ¯ããã©ã³ã¹ã®åããé£äºãç¡çã®ãªãç¯å²ã§ã®é©åºŠãªéåãã¹ãã¬ã¹ç®¡çïŒãªã©ã¯ãŒãŒã·ã§ã³ããã€ã³ããã«ãã¹ãªã©ïŒã¯ãçç¶ã®è»œæžã«åœ¹ç«ã€å¯èœæ§ããããŸãã
å¿ççæ³ã¯éžæè¢ã®äžã€ïŒä»åã®ç ç©¶ã§ã¯ææãªå¹æãèŠãããŸããã§ããããå¿ççæ³ïŒèªç¥è¡åçæ³ãæ¯æç粟ç¥çæ³ãªã©ïŒã¯ãçç¶ã«äŒŽã粟ç¥çãªèŠçãåããã察åŠã¹ãã«ãåäžããã广ãæåŸ
ã§ããŸããåå¥ã®ã«ãŠã³ã»ãªã³ã°ããããç¹åããããã°ã©ã ãæå¹ãªå ŽåããããŸãã
åšå²ã®çè§£ãšãµããŒããæ±ããïŒå®¶æãå人ãè·å Žã®äººã
ã«çç¶ã«ã€ããŠèª¬æããçè§£ãšååãæ±ããããšãéèŠã§ããå¿
èŠã§ããã°ãå
¬çãªæ¯æŽå¶åºŠãæ£è
äŒãªã©ã掻çšããŸãããã
çŠãããå°ããªç®æšããå§ããïŒå埩ã«ã¯æéããããããšããããŸããçŠãããéæå¯èœãªå°ããªç®æšãèšå®ããå°ããã€æ¥åžžçæŽ»ã®æŽ»åã¬ãã«ãäžããŠããããšã倧åã§ãã
ð§ç ç©¶ã®éçãšä»åŸã®èª²é¡
ãã®ç ç©¶ã«ã¯ããã€ãã®éçããããŸãã
åå è
æ°ã®å°ãªãïŒ48åãšããåå è
æ°ã¯ãçµ±èšçãªæ€åºåã確ä¿ããã«ã¯ååãšã¯èšãããçµæã®è§£éã«ã¯æ
éããæ±ããããŸãã
è©äŸ¡é
ç®ã®é宿§ïŒèº«äœçç¶ã®è² æ
床ãäžè¬çãªç²Ÿç¥çç¶ã«çŠç¹ãåœãŠãŠããŸããããã³ããåŸéºçã®å€æ§ãªçç¶ïŒäŸãã°ãç¹å®ã®èªç¥æ©èœé害ã®åŽé¢ããç²åŽã®è³ªãªã©ïŒãè©³çŽ°ã«æããã«ã¯äžååã ã£ãå¯èœæ§ããããŸãã
ä»å
¥ã®æè»æ§ïŒããã¥ã¢ã«ã¬ã€ãã«æ²¿ã£ãéå£çæ³ã§ãã£ããããåã
ã®æ£è
ããã®è€éãªããŒãºã«ååã«å¯Ÿå¿ã§ããªãã£ãå¯èœæ§ãèããããŸãã
ä»åŸã®ç ç©¶ã§ã¯ããããã®éçãå æãããã广çãªä»å ¥æ¹æ³ãèŠã€ããããã®èª²é¡ãæ®ãããŠããŸãã
å€§èŠæš¡ãªç ç©¶ïŒããå€ãã®åå è
ã察象ãšããå€§èŠæš¡ãªç ç©¶ãå¿
èŠã§ãã
倿§ãªè©äŸ¡é
ç®ïŒèº«äœçç¶ã ãã§ãªããèªç¥æ©èœãçæŽ»ã®è³ªã瀟äŒåå 床ãç¹å®ã®çç¶ïŒäŸïŒãã¬ã€ã³ãã©ã°ã®å
·äœçãªåŽé¢ïŒãªã©ãå€è§çãªè©äŸ¡é
ç®ãå°å
¥ããããšãéèŠã§ãã
åå¥åãããã¢ãããŒãïŒéå£çæ³ãšäžŠè¡ããŠãåå¥ã®ããŒãºã«å¿ããæè»ãªä»å
¥ããç¹å®ã®çç¶ãããã¡ã€ã«ïŒäŸïŒé床ã®ç²åŽããã©ãŠãæŽïŒãæã€æ£è
ããã察象ãšããç¹ååããã°ã©ã ã®éçºãæåŸ
ãããŸãã
é·æçãªè¿œè·¡èª¿æ»ïŒä»å
¥å¹æãé·æçã«æç¶ãããã©ãããè©äŸ¡ããããã«ãããé·ãæéã®è¿œè·¡èª¿æ»ãå¿
èŠã§ãã
ãŸãšã
ä»åã®ç ç©¶ã¯ãã³ããåŸéºçæ£è ããã«å¯Ÿããéå£å¿ççæ³ã®å¹æãæ€èšŒãã貎éãªè©Šã¿ã§ãããã身äœçç¶ãæãã€ãäžå®ã®ãããã«ãããŠããå¯Ÿç §çŸ€ãšæ¯èŒããŠçµ±èšçã«ææãªåªäœæ§ã瀺ãã«ã¯è³ããŸããã§ããããã®çµæã¯ãåå è æ°ã®å°ãªããè©äŸ¡é ç®ã®é宿§ãšãã£ãç ç©¶ã®éçãèæ ®ããæ éã«è§£éããå¿ èŠããããŸããã³ããåŸéºçã®çç¶ã¯éåžžã«å€æ§ã§ãããç»äžçãªã¢ãããŒãã§ã¯å¯Ÿå¿ãé£ããå¯èœæ§ããããŸããä»åŸã¯ãããå€§èŠæš¡ãªç ç©¶ã倿§ãªè©äŸ¡é ç®ããããŠåã ã®æ£è ããã®ããŒãºã«åãããæè»ãªä»å ¥æ¹æ³ã®éçºãæ±ããããŸããã³ããåŸéºçã«æ©ãæ¹ã ãé©åãªãµããŒããåããããè¯ãçæŽ»ãéããããããããªãç ç©¶ãšèšåºå®è·µã®é²å±ãæåŸ ãããŸãã
ðé¢é£ãªã³ã¯é
åçåŽåçïŒæ°åã³ãããŠã€ã«ã¹ææçã®åŸéºçã«ã€ããŠ
https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00326.html
åœç«åœéå»çç ç©¶ã»ã³ã¿ãŒïŒã³ããåŸéºçã«ã€ããŠ
https://www.ncgm.go.jp/covid19/long-covid/
æ¥æ¬ç²Ÿç¥ç¥çµåŠäŒïŒç²Ÿç¥çŸæ£ã«ã€ããŠ
https://www.jspn.or.jp/modules/forpublic/
äžçä¿å¥æ©é¢ (WHO)ïŒPost COVID-19 condition (Long COVID) (è±èª)
https://www.who.int/news-room/questions-and-answers/item/long-covid-post-covid-19-condition
æžèªæ å ±
| DOI | pii: 1088. doi: 10.1186/s40359-026-05149-2 |
|---|---|
| PMID | 42487142 |
| PubMed URL | https://pubmed.ncbi.nlm.nih.gov/42487142/ |
| çºè¡å¹Ž | 2026 |
| èè å | Rometsch Caroline, Colditz Kimberly, Elgner Melanie, Allwang Christine, Zipfel Stephan, Junne Florian, Binneböse Marius |
| èè æå± | Department of Psychosomatic Medicine and Psychotherapy, Medical University Hospital Tuebingen, Osianderstr.5, TÃŒbingen, 72076, Germany. Caroline.Rometsch@med.uni-tuebingen.de.; Medical Faculty, University Clinic for Psychosomatic Medicine and Psychotherapy, University Medicine, Otto-Von-Guericke-University Magdeburg, Leipziger Str. 44, Magdeburg, 39120, Germany.; TUM School of Medicine and Health, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.; Department of Psychosomatic Medicine and Psychotherapy, Medical University Hospital Tuebingen, Osianderstr.5, TÃŒbingen, 72076, Germany. |
| éèªå | BMC Psychol |